Identifying p53 Target Genes Using Hypomorphic Variants.

Bibek Bhatta, Tomer Cooks

Cancer discovery 2023 Jul 07

filter terms:

all
compound
gene and proteins
show more »
show less «

The reduced tumor suppression activity of hypomorphic variants of the TP53 gene was used by Indeglia and colleagues to corroborate PADI4 as a p53 target. The study makes a noteworthy advancement in comprehending the downstream implications of TP53-PDI4, including potential predictions of survival and the efficacy of immunotherapy. See related article by Indeglia et al., p. 1696 (4). ©2023 American Association for Cancer Research.